4 / 17
Page 42
conference
series.
com
Day-1
Sessions
Therapeutic Targets and Mechanisms for Treatment | Animal Models and Translational Medicine | Alzheimer’s
disease Pathophysiology and Disease Mechanisms | Dementia with Lewy Bodies | Managing Dementia | Care Practice
and Awareness
Chair:
Magdalena Turek,
Care Homes Zapiecek, Poland
Session Introduction
Title:
Early brain connectivity alterations before amyloid deposition in a rat model of Alzheimer’s disease
Guadalupe Soria,
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain
Title:
A case study on the successful transition for seniors living with Alzheimer’s disease from an aged
care residential facility to a domestic environment
Emily Gillett,
The CareSide, Australia
Title:
Yolkin polypeptide complex from hen egg yolk – isolation, characterization and neuroprotective
activity
W Kazana,
Hirszfeld Institute of Immunology and Experimental Therapy-Polish Academy of Sciences,
Poland
Title:
Boosting brain insulin signaling to combat neurotoxicity arising in type 2 diabetes
Shaymaa Abdulghaffar Abdulmalek,
Alexandria University, Egypt
Title:
In silico
identification of novel ApoE4 inhibitor for Alzheimer’s disease therapy
Muhammad Asif Rasheed,
COMSATS University Islamabad, Pakistan
Title:
Carbamylated erythropoietin-FC protects hippocampus against Aβ induced memory deterioration
in a rat model of Aβ toxicity: Considering Akt/GSK-3β, MAPKs and MMP-2
Etrat Hooshmandi,
Shahid Beheshti University of Medical Sciences, Iran